science1 distinct publisher
Psilocybin Heads Into Anorexia Trials, Where the Bar for Progress Is a 5% Death Rate
Scientific American's Science Quickly walked through early psilocybin research in anorexia nervosa. The condition kills about 5% of patients within four years of diagnosis, which is the real story.
Publishers:scientificamerican.com
Reality
- Evidence32
- Adoption9
- Hype gap+14
- Incentives44
- Confidence33